Phanes Therapeutics Announces Expansion Of Clinical Trial Collaboration And Supply Agreement With Merck
MRK•Merck and Phanes expand collaboration
Merck & Co Inc and Phanes Therapeutics are expanding their clinical trial collaboration and supply agreement.
Phanes Therapeutics said it will evaluate spevataimig in combination with Keytruda and chemotherapy for the treatment of biliary tract cancer.
